State University of Londrina   Report issue

Academic/Hospital Phase 4
Founded: Londrina Brazil (1970)

Organization Overview

First Clinical Trial
2003
NCT00317005
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nephrology, University Hospital, State University of Londrina | State University of Londrina

Active Ingredients

Drugs in Phase 4 Trials (1)

folic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 4)

Hyperhomocysteinemia (Phase 4)

Kidney Failure, Chronic (Phase 4)

Uremia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1